BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) today announced that it plans to complete a private placement financing (the “Financing”) for up to $3,000,000 of gross proceeds, consisting of up to 3,000,000 units (the “Units”) at a price of $1.00 per Unit. Each Unit will consist of $1.00 principal amount of secured convertible notes (the “Notes”) and five (5) common share purchase warrants of the Company (the “Warrants”). The Financing m
The informative cannabis social network. Join groups, make friends and be part of the cannabis community! Share your recipes, product & strain reviews, tutorials and more! Log in or register to continue
Stock Ticker
- Loading stock data...
Categories
Recent Posts
- Green Check Honored With PBC Top Compliance Company Award
- Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
- Enveric Biosciences to Present Poster Highlighting EVM301 Series at the International Conference on Molecular Biology and Biochemistry 2023
- Method Man’s TICAL Official Cannabis Brand Launches in New York City
- LEXI Announces Appointment of Jason Nalewanyj as Chief Financial Officer and Highlights Significant Company Progress
More from this user
